Unique ID issued by UMIN | UMIN000022982 |
---|---|
Receipt number | R000026494 |
Scientific Title | Study of ethanol lock therapy & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port |
Date of disclosure of the study information | 2016/08/01 |
Last modified on | 2016/07/01 22:46:46 |
Study of ethanol lock therapy & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port
Study of ethanol lock therapy & antimicrobial lock therapy
Study of ethanol lock therapy & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port
Study of ethanol lock therapy & antimicrobial lock therapy
Japan |
Case of catheter-related bloodstream infection in totally implantable central venous port
Infectious disease | Surgery in general | Hepato-biliary-pancreatic surgery |
Others
NO
The purpose of the study is to assess the efficacy and safety of ethanol lock & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port.
Safety,Efficacy
To evaluate the efficacy of antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port.
To evaluate the safety of antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
70% ethanol lock therapy (7 days)
Antimicribial lock therapy (7-14 days)
Systemic antimicrobial therapy (14-21 days)
20 | years-old | <= |
Not applicable |
Male and Female
Patients who underwent home parenteral nutrition by totally implantable central venous port.
2. fever more than 38.0 degree.
3. catheter-related bloodstream infection is suspected.
4. No severe complication by sepsis. General condition is good.
5. No allergy for antimicrobial drugs or ethanol which will be used in this study.
6. Silicine catheter was implanted
1.Patients with severe sepsis
2.Patients who underwent lock therapy for bacterial infection within 3 months
3.Patients who underwent lock therapy for fungal infection
4.Patients with pregnancy
5. Patients who doctors regarded as inadequate to participate this study.
45
1st name | |
Middle name | |
Last name | Kazuhiro Watanabe |
Tohoku University Hospital
Gastrointestinal Surgery
1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi
022-717-7205
k-wata@surg1.med.tohoku.ac.jp
1st name | |
Middle name | |
Last name | Kazuhiro Watanabe |
Tohoku University Hospital
Gastrointestinal Surgery
1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi
022-717-7205
k-wata@surg1.med.tohoku.ac.jp
Division of Gastrointestinal Surgery, Tohoku University Hospital
Division of Gastrointestinal Surgery, Tohoku University Hospital
Other
NO
2016 | Year | 08 | Month | 01 | Day |
Unpublished
Preinitiation
2016 | Year | 07 | Month | 01 | Day |
2016 | Year | 08 | Month | 01 | Day |
2016 | Year | 07 | Month | 01 | Day |
2016 | Year | 07 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026494